A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
Dec 07, 2023
―
Dexamethasone Ophthalmic Suspension, Vehicle Of Ocs-01
Cataract, Inflammation Eye, Pain, Postoperative
Phase III
Terminated
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
Nov 07, 2023
―
Artificial Tears, Licaminlimab, Vehicle Of Ocs-02
Dry Eye Disease
Phase II
Completed
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
May 31, 2023
―
Vehicle, Ocs-01
Inflammation Eye Pain, Postoperative Cataract
Phase III
Completed
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
OCS-01 in Treating Inflammation and Pain in Post-cataract Patients
Oct 16, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oculis Holding (OCS) have in its pipeline
OCS is currently developing the following drugs: Vehicle, Dexamethasone Ophthalmic Suspension (Ocs-01), Dexamethasone Ophthalmic Suspension, Vehicle Of Ocs-01, Artificial Tears, Licaminlimab, Vehicle Of Ocs-02. These drug candidates are in various stages of clinical development as the company works toward FDA approval.